Cepheid

06/19/2026

🦠 Antimicrobial resistance (AMR) is often described as a “silent pandemic”, but for pediatric care, its impact is immediate and deeply personal.

🩺 Children are uniquely vulnerable. With developing immune systems and limited pediatric-specific data, clinicians often face difficult decisions amid rising resistance and shrinking treatment options.

📑 In our latest Insight Hub article, we explore why diagnostics and education are critical to improving decision-making, supporting antimicrobial stewardship, and ultimately protecting the most vulnerable patients.

💡 From guiding timely treatment to reducing uncertainty in care, diagnostics play a central role in strengthening the AMR response, especially in children.

https://ow.ly/Uzzb50Z7itJ

A pediatric perspective on antimicrobial resistance, exploring vulnerability, difficult decisions, and why diagnostics and education matter.

06/18/2026

💡 From symptoms to action. From uncertainty to confidence.

👉 Join Professor Valeria Cento and Dr. Christophe Martinaud for a live webinar on how a stewardship-led approach to syndromic GI testing can help support fast, informed clinical decision-making. Discover how broader pathogen coverage, rapid turnaround time, and targeted test selection can help optimize diagnostic pathways, support antimicrobial stewardship, and patient management.

🗓 25 June 2026 🕓 16:00 CET | 15:00 BST | 10:00 EDT✅ Free to attend🎥 Recording available for all registrants. Translations available

Click here to reserve your spot:
https://selectscience.streamgo.live/from-symptoms-to-action-a-stewardship-led-approach-to-syndromic-gi-testing/register

06/17/2026

Join us on July 2nd for an impactful webinar: “Making the Right Respiratory Diagnostic Choice at the Right Time: Understanding Timing, Accuracy, and Diagnostic Scope to Support Clinical Decision-Making.” This educational initiative, brought to you by APSR and supported by Cepheid, will feature leading voices in respiratory care sharing valuable insights on timing, accuracy, and diagnostic scope.

Don't miss this opportunity to enhance your clinical decision-making! Register:
https://ow.ly/uCKs50ZaFen

MedicalEducation -19

06/16/2026

“Because smells like it… isn’t a diagnosis.” When patients present with vaginitis symptoms, they’re looking to you for clear answers—not variability. Even though Amsel’s criteria are a standard for BV, differences in clinical assessment can create diagnostic challenges that may impact clinical management and follow-up. Xpert® Xpress MVP (Multiplex Vaginal Panel) detects DNA targets associated with BV, Candidiasis, and Trichomoniasis—in ~60 minutes.

Learn more at: https://ow.ly/OgWe50Z8XpI

06/15/2026

Join the Cepheid symposium at the 11th FIDSSA Congress as we explore how rapid PCR is transforming the diagnosis and management of GI infections. With overlapping symptoms and delayed results still challenging clinical care, there’s a growing need for fast, actionable insights to guide treatment and improve outcomes.

🕒 19 June 2026 |12:30–13:30 |
📍 Meeting Room 1.41-14.2, CTICC, Cape Town

Hear from our speakers as they unpack clinical challenges and the role of syndromic testing and integrated diagnostic approaches.

👉 Join us to discover how faster diagnostics can support better patient outcomes

06/15/2026

We’re excited to be attending the Australian Society for Microbiology Annual National Meeting!

Join us at Booth #2 from 15–18 June to explore Cepheid’s latest innovations in molecular diagnostics and see how fast testing is helping to transform healthcare delivery — from laboratory workflows to patient care and community health outcomes.

We look forward to connecting with you there.


Learn more: https://www.theasmmeeting.org.au/

06/12/2026

📢 Cepheid is committed to supporting the global response to the Ebola Bundibugyo (BDBV) outbreak. Xpert® Hemorrhagic Fever panel tests are now available in Africa, helping strengthen diagnostic capacity in the Democratic Republic of the Congo and Uganda following the WHO’s Public Health Emergency of International Concern declaration on May 17, 2026.

📰Read the full press release: https://ow.ly/714550Zb5gQ

IVD. In Vitro Diagnostic Medical Device. Not available in all countries.

06/12/2026

🧫 Catching Resistance Before It Spreads. Humanitas Research Hospital in Milan, Italy, is tackling rising drug‑resistant infections with early molecular screening, identifying carriers sooner, preventing outbreaks, and protecting vulnerable patients. Faster results and targeted action are helping the team stay ahead of MDROs while optimizing hospital resources.

📰 Read the full article to learn how early screening strengthens prevention:
https://ow.ly/BmJy50Z5mFy

06/11/2026

☝️ What if every treatment decision started with better diagnostics?

🎤 In this Cepheid Talks podcast episode, Dr. Ephraim Tsalik shares his perspective on the evolving role of diagnostics in clinical decision-making and antimicrobial resistance (AMR).

💫 From advancing innovation to enabling more precise, timely care, this conversation explores how diagnostics can help shape better outcomes for both clinicians and patients.

Tune in now: https://ow.ly/CgoJ50Z7oxz

06/10/2026

💡At ESCMID Global 2026, Cepheid explored a critical question facing modern diagnostics: How do we balance precision today with the power of what’s next? In our integrated symposium, we took a practical look at diagnostic stewardship, from smart panels to metagenomics, and their role in clinical decision-making.

Missed the session? Catch up on the conversation: 🔗 https://ow.ly/t2V550Z7Qtj